Gydytojų Keršanskų klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 493,664 | 582,510 | 585,296 | 751,131 | 784,078 | 875,214 | 1,062,185 | 1,113,257 |
| Profit before tax | - | - | 166,060 | 146,084 | 93,030 | 59,470 | 81,739 | 55,597 |
| Net profit | 180,116 | 185,497 | 147,715 | 136,190 | 87,578 | 55,973 | 81,739 | 46,148 |
| Equity | 426,430 | 395,710 | 536,879 | 673,069 | 760,647 | 816,620 | 598,359 | 544,508 |
| Liabilities | 56,526 | 62,736 | 79,024 | 104,602 | 112,561 | 128,900 | 103,709 | 119,697 |
| Non-current assets | 97,757 | 99,494 | 89,763 | 134,381 | 304,903 | 296,953 | 213,810 | 396,300 |
| Current assets | 385,199 | 358,952 | 546,314 | 663,521 | 588,338 | 667,798 | 508,033 | 287,667 |
| Total assets | 482,956 | 458,446 | 636,077 | 797,902 | 893,241 | 964,751 | 721,843 | 683,967 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 118,921 | 238,005 | 162,482 |
| Social insurance contributions | - | - | - | - | - | 137,272 | 168,470 | 179,210 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +21.7% | +18.0% | +0.5% | +28.3% | +4.4% | +11.6% | +21.4% | +4.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 37.3% | 40.5% | 23.2% | 17.1% | 9.8% | 5.8% | 11.3% | 6.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 42.2% | 46.9% | 27.5% | 20.2% | 11.5% | 6.9% | 13.7% | 8.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 36.5% | 31.8% | 25.2% | 18.1% | 11.2% | 6.4% | 7.7% | 4.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 28.4% | 19.4% | 11.9% | 6.8% | 7.7% | 5.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,700 | 17,832 | 18,680 | 24,230 | 22,087 | 21,835 | 26,778 | 28,363 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gydytojų Keršanskų klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-16 | 2026-07-17 | 16551.05 |
| 2026-05-17 | 2026-05-17 | 14788.68 |
| 2026-05-12 | 2026-05-14 | 0.03 |
| 2026-04-27 | 2026-04-29 | 22.55 |
| 2026-02-18 | 2026-02-22 | 14622.50 |
| 2026-01-22 | 2026-01-22 | 22.62 |
| 2025-12-16 | 2025-12-17 | 14180.80 |
| 2025-10-23 | 2025-10-27 | 62.93 |
| 2025-10-16 | 2025-10-16 | 15170.88 |
| 2025-09-16 | 2025-09-16 | 15206.93 |
| 2025-07-29 | 2025-08-03 | 68.82 |
| 2025-07-28 | 2025-07-28 | 12425.80 |
| 2025-07-26 | 2025-07-27 | 14723.72 |
| 2025-07-24 | 2025-07-25 | 14792.54 |
| 2025-07-16 | 2025-07-23 | 14723.72 |
| 2025-06-17 | 2025-06-22 | 15129.57 |
| 2025-05-16 | 2025-05-19 | 14691.76 |
| 2025-04-24 | 2025-04-27 | 13.61 |
| 2025-04-16 | 2025-04-21 | 15116.07 |
| 2025-03-18 | 2025-03-18 | 14980.30 |
| 2025-02-18 | 2025-02-18 | 7499.36 |
| 2024-02-19 | 2024-03-14 | 0.64 |
| 2024-01-23 | 2024-02-14 | 0.64 |
| 2023-10-30 | 2023-11-14 | 0.68 |
| 2023-10-25 | 2023-10-25 | 0.68 |
| 2023-10-17 | 2023-10-19 | 551.15 |
| 2023-09-18 | 2023-09-20 | 349.26 |
| 2023-07-18 | 2023-07-20 | 57.29 |
| 2023-01-20 | 2023-01-22 | 2.58 |
Gydytojų Keršanskų klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-17 | 2026-08-17 | 11131.74 |
| 2026-05-19 | 2026-05-20 | 123.1 |
| 2026-05-17 | 2026-05-18 | 13716.33 |
| 2026-03-13 | 2026-03-17 | 12438.24 |
| 2026-02-16 | 2026-02-21 | 55.83 |
| 2026-01-17 | 2026-01-18 | 9.92 |
| 2025-11-18 | 2025-11-18 | 44.1 |
| 2025-10-16 | 2025-10-19 | 4.51 |
| 2025-09-13 | 2025-09-17 | 0.85 |
| 2025-08-19 | 2025-08-19 | 3351.66 |
| 2025-08-17 | 2025-08-18 | 3349.11 |
| 2025-08-16 | 2025-08-16 | 3336.36 |
| 2025-08-15 | 2025-08-15 | 3287.26 |
| 2025-07-27 | 2025-07-28 | 9236.27 |
| 2025-07-21 | 2025-07-26 | 9221.45 |
| 2025-07-20 | 2025-07-20 | 9211.57 |
| 2025-07-17 | 2025-07-19 | 9212.67 |
| 2025-07-16 | 2025-07-16 | 9296.66 |
| 2025-05-31 | 2025-05-31 | 331.02 |
| 2025-05-20 | 2025-05-20 | 76.12 |
| 2025-04-25 | 2025-04-28 | 103.94 |
| 2025-04-22 | 2025-04-24 | 8.94 |
| 2025-04-20 | 2025-04-21 | 11150.36 |
| 2025-04-19 | 2025-04-19 | 11141.42 |
| 2025-04-17 | 2025-04-18 | 11141.71 |
| 2025-04-16 | 2025-04-16 | 11144.35 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gydytoju Keršansku klinika, UAB (code 251286210) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €1.11M, up 4.8% year on year and 27.2% over two years. Net profit was €46.1K, below the €81.7K recorded in 2024 and €56.0K in 2023, which reduced the latest profit margin to 4.1% from 7.7% in 2024. The business remains profitable, but earnings weakened in the latest year despite continued revenue growth.
The balance sheet also contracted over the period. Total assets declined to €684.0K in 2025 from €721.8K in 2024 and €964.8K in 2023, while equity fell to €544.5K from €598.4K and €816.6K. Liabilities were €119.7K in 2025, slightly above the €103.7K in 2024. Key indicators for 2025 show ROE of 8.5%, ROA of 6.8%, debt-to-equity of 0.22, and asset turnover of 1.63x. Revenue per employee was €28.5K and profit per employee €1.2K.
The balance sheet also contracted over the period. Total assets declined to €684.0K in 2025 from €721.8K in 2024 and €964.8K in 2023, while equity fell to €544.5K from €598.4K and €816.6K. Liabilities were €119.7K in 2025, slightly above the €103.7K in 2024. Key indicators for 2025 show ROE of 8.5%, ROA of 6.8%, debt-to-equity of 0.22, and asset turnover of 1.63x. Revenue per employee was €28.5K and profit per employee €1.2K.